Khloe Kardashian's turn as a celebrity endorser for Biohaven's Nurtec represented a new kind of pharma celebrity role as patient, social influencer and team player.

The new phar­ma celebri­ties: Fa­mous pa­tients with so­cial in­flu­ence are ‘just get­ting start­ed’

Bio­haven CEO Vlad Coric doesn’t fit the mold of a typ­i­cal “Keep­ing up with the Kar­dashi­ans” view­er. How­ev­er, he had a spe­cif­ic rea­son to watch a few years ago. One of the fa­mous re­al­i­ty sis­ters, Khloé, was suf­fer­ing with mi­graines, de­scrib­ing de­bil­i­tat­ing symp­toms of se­vere pain and throw­ing up dur­ing the se­ries film­ing.

As a physi­cian and neu­rol­o­gy spe­cial­ist — and the head of a bio­phar­ma with then-new mi­graine oral med Nurtec — he want­ed to know if she had heard of, or tried, any of the new class of cal­ci­tonin gene-re­lat­ed pep­tide (CGRP) in­hibitors.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.